Evidence map›Paper›PMID 35087050›Full record

ArticleNPJ biofilms and microbiomes2022

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation.

Suraphan Panyod, Wei-Kai Wu, Pei-Chen Chen, Kent-Vui Chong, Yu-Tang Yang, Hsiao-Li Chuang, Chieh-Chang Chen, Rou-An Chen, Po-Yu Liu, Ching-Hu Chung and 11 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05803759 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2025Enrolled200ConditionsMyocardial Ischemia, Coronary Artery Bypass Grafting, Coronary Arteriosclerosis, Percutaneous Coronary RevascularizationArmsAllicor, Placebo
NCT05813171 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2024Enrolled300ConditionsAtherosclerosis, Peripheral Arterial DiseaseArmsAllicor, Placebo
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Gut microbes · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Association of Copper with Atherosclerosis and Treatment Strategies.Journal of cardiovascular translational research · 2025
    Review
  8. Review
  9. Trimethylamine-Annals of medicine · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. The microbial metabolite trimethylamine N-oxide and the kidney diseases.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 4 countries.

Suraphan Panyod *Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.ORCID http://orcid.org/0000-0001-8998-375X
Wei-Kai Wu *Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-9476-8998
Pei-Chen ChenInstitute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.
Kent-Vui ChongInstitute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.
Yu-Tang YangDepartment of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Hsiao-Li ChuangNational Laboratory Animal Center, National Applied Research Laboratories, Taipei, Taiwan.
Chieh-Chang ChenDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0003-2953-210X
Rou-An ChenInstitute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.
Po-Yu LiuDepartment of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID http://orcid.org/0000-0003-1290-0850
Ching-Hu ChungDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Huai-Syuan HuangInstitute of Food Science and Technology, National Taiwan University, Taipei, Taiwan.
Angela Yu-Chen LinGraduate Institute of Environmental Engineering, National Taiwan University, Taipei, Taiwan.
Ting-Chin David ShenDivision of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kai-Chien YangDepartment and Graduate Institute of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan.
Tur-Fu HuangDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan.
Cheng-Chih HsuDepartment of Chemistry, National Taiwan University, Taipei, Taiwan.
Chi-Tang HoDepartment of Food Science, Rutgers University, New Brunswick, NJ, USA.
Hsien-Li KaoDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Alexander N OrekhovInstitute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.
Ming-Shiang WuDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. mingshiang@ntu.edu.tw.ORCID http://orcid.org/0000-0002-1940-6428
Lee-Yan SheenInstitute of Food Science and Technology, National Taiwan University, Taipei, Taiwan. lysheen@ntu.edu.tw.ORCID http://orcid.org/0000-0001-5541-652X
National Taiwan University · TWNational Taiwan University Hospital · TWMackay Medical University · TWNational Institutes of Applied Research · TWNational Taiwan University of Science and Technology · TWResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RURutgers, The State University of New Jersey · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) is strongly associated with the gut microbiota and its metabolites, including trimethylamine-N-oxide (TMAO), formed from metaorganismal metabolism of ʟ-carnitine. Raw garlic juice, with allicin as its primary compound, exhibits considerable effects on the gut microbiota. This study validated the benefits of raw garlic juice against CVD risk via modulation of the gut microbiota and its metabolites. Allicin supplementation significantly decreased serum TMAO in ʟ-carnitine-fed C57BL/6 J mice, reduced aortic lesions, and altered the fecal microbiota in carnitine-induced, atherosclerosis-prone, apolipoprotein E-deficient (ApoE

Indexed as

AtherosclerosisGarlicGastrointestinal MicrobiomeAnimalsDisulfidesHumansMethylaminesMiceMice, Inbred C57BLOxidesSulfinic AcidsallicinDisulfidesMethylaminesOxidesSulfinic Acidstrimethylaminetrimethyloxamine

Identifiers

PMID35087050
PMCPMC8795425
OpenAlexW4226228246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.